Your browser doesn't support javascript.
loading
Imatinib mesylate in the treatment of gastrointestinal stromal tumor related adverse reaction and prevention strategies / 国际外科学杂志
International Journal of Surgery ; (12): 488-493, 2015.
Article in Chinese | WPRIM | ID: wpr-478064
Responsible library: WPRO
ABSTRACT
Molecular targeted therapy is a treatment bed emerging recent years for the treatment of malignant tumors,imatinib mesylate in the treatment of gastrointestinal stromal tumor (GIST) is a successful example ofmolecular targeted therapy.Imatinib mesylate can inhibit tyrosine kinase andinhibition of cell proliferation by treatment of gastrointestinal stromal tumor.With the positive effect of imatinib in the treatment of GIST,the related adverse reactions and the prevention and treatment strategies are worth to be discussed.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: International Journal of Surgery Year: 2015 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: International Journal of Surgery Year: 2015 Type: Article